Terns Pharmaceuticals Inc

NASDAQ:TERN   3:59:44 PM EDT
16.40
+0.49 (+3.08%)
Earnings Announcements

Terns Reports Fourth Quarter And Full Year 2020 Financial Results

Published: 03/30/2021 20:36 GMT
Terns Pharmaceuticals Inc (TERN) - Terns Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Update.
Terns Pharmaceuticals Inc Quarterly Loss per Share $3.65.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.73

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.78

More details on our Analysts Page.